Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Medicinal Plants and Bioactive Natural Products As Inhibitors of Nlrp3 Inflammasome Publisher Pubmed

Summary: A review suggests plant compounds reduce inflammation in chronic diseases, offering natural treatment options. #Inflammation #NaturalRemedies

Bagherniya M1, 2 ; Khedmatgozar H3 ; Fakheran O4 ; Xu S5 ; Johnston TP6 ; Sahebkar A7, 8, 9, 10
Authors

Source: Phytotherapy Research Published:2021


Abstract

The NLR family, pyrin domain-containing 3 (NLRP3) inflammasome is a multiprotein complex that induces caspase-1 activation and the downstream substrates involved with the processing and secretion of the pro-inflammatory cytokines interleukin-1β (IL-1β) and IL-18 and tumor necrosis factor-α (TNF- α). The NLRP3 inflammasome is activated by a wide range of danger signals that derive from metabolic dysregulation. Activation of this complex often involves the adaptor ASC and upstream sensors including NLRP1, NLRP3, NLRC4, AIM2, and pyrin, which are activated by different stimuli including infectious agents and changes in cell homeostasis. It has been shown that nutraceuticals and medicinal plants have antiinflammatory properties and could be used as complementary therapy in the treatment of several chronic diseases that are related to inflammation, for example, cardiovascular diseases and diabetes mellitus. Herb-based medicine has demonstrated protective effects against NLRP3 inflammasome activation. Therefore, this review focuses on the effects of nutraceuticals and bioactive compounds derived from medicinal plants on NLRP3 inflammasome activation and the possible mechanisms of action of these natural products. Thus, herb-based, natural products/compounds can be considered novel, practical, and accessible agents in chronic inflammatory diseases by inhibiting NLRP3 inflammasome activation. © 2021 John Wiley & Sons Ltd.
Other Related Docs
18. Does Curcumin Have an Anticaries Effect? a Systematic Review of in Vitro Studies, Advances in Experimental Medicine and Biology (2021)